transforming-growth-factor-beta and Gram-Negative-Bacterial-Infections

transforming-growth-factor-beta has been researched along with Gram-Negative-Bacterial-Infections* in 10 studies

Trials

1 trial(s) available for transforming-growth-factor-beta and Gram-Negative-Bacterial-Infections

ArticleYear
Chitosan-Ocimum basilicum nanocomposite as a dietary additive in Oreochromis niloticus: Effects on immune-antioxidant response, head kidney gene expression, intestinal architecture, and growth.
    Fish & shellfish immunology, 2022, Volume: 128

    Several studies have looked into the use of basil, Ocimum basilicum (L.) in aquaculture as a dietary additive; however, more research is needed to see the possibility of it's including in nanocarriers in aquafeeds. An experiment was undertaken to highlight the efficacy chitosan-Ocimum basilicum nanocomposite (COBN), for the first time, on Nile tilapia (Oreochromis niloticus) growth, stress and antioxidant status, immune-related parameters, and gene expression. For 60 days, fish (average weight: 23.55 ± 0.08 g) were fed diets provided with different concentrations of COBN (g/kg): 0 g [COBN0], 1 g [COBN1], 2 g [COBN2], and 3 g [COBN3], where COBN0 was kept as control diet. Following the trial, the fish were challenged with pathogenic bacteria (Aeromonas sobria) and yeast (Candida albicans) infection. In comparison to the control (COBN0), a notable increase in growth parameters (weight gain, feed intake, and specific growth rate) and intestinal morphometric indices (average intestinal goblet cells count, villous width, and length) in all COBN groups was observed, where COBN2 and COBN3 groups had the highest values. The COBN diets significantly (p < 0.05) declined levels of serum triglycerides, glucose, cholesterol, and hepatic malondialdehyde. Moreover, the higher levels of serum biochemical biomarkers (growth hormone, total protein, globulin, and albumin), immunological parameters (phagocytic activity%, nitric oxide, and lysozyme), and hepatic antioxidant parameters (superoxide dismutase, total antioxidant capacity, and glutathione peroxidase) were obvious in the COBN2 and COBN3 groups followed by COBN1. The immune-antioxidant genes (TNF-α, IL-10, IL-1β, TGF-β, GPx, and SOD) were found to be considerably up-regulated in all COBN groups (COBN2 and COBN3 followed by COBN1). Fifteen days post-challenge with A. sobria and C. albicans, the highest survival rate was recorded in the COBN2 group (83.33 and 91.67%) followed by the COBN3 group (75 and 83.33%), respectively. The findings showed that a dietary intervention with COBN can promote growth, intestinal architecture, immunity, and antioxidant markers as well as protect O. niloticus against A. sobria and C. albicans infection. As a result, the COBN at a dose of 2 g/kg could be used as a food additive for the sustainable aquaculture industry.

    Topics: Albumins; Animal Feed; Animals; Antioxidants; Chitosan; Cichlids; Diet; Dietary Supplements; Fish Diseases; Food Additives; Gene Expression; Glucose; Glutathione Peroxidase; Gram-Negative Bacterial Infections; Growth Hormone; Head Kidney; Interleukin-10; Malondialdehyde; Muramidase; Nanocomposites; Nitric Oxide; Ocimum basilicum; Superoxide Dismutase; Transforming Growth Factor beta; Triglycerides; Tumor Necrosis Factor-alpha

2022

Other Studies

9 other study(ies) available for transforming-growth-factor-beta and Gram-Negative-Bacterial-Infections

ArticleYear
SCFAs improve disease resistance via modulate gut microbiota, enhance immune response and increase antioxidative capacity in the host.
    Fish & shellfish immunology, 2022, Volume: 120

    To evaluate the effects of dietary short chain fatty acids (SCFAs) on the intestinal health and innate immunity in crucian carp, a six-week feeding trial was carried out with following treatments: basal diet (BD), basal diet supplementation with 1% sodium acetate (BDSA), basal diet supplementation with 1% sodium propionate (BDSP) and basal diet supplementation with 1% sodium butyrate (BDSB). The results showed dietary BDSA, BDSP and BDSB could protect the host against oxidative stress by improving the activity of certain antioxidative enzymes (T-SOD, GSH-Px and CAT). Additionally, dietary SCFAs could enhance mucosal and humoral immune responses by improving certain innate immune parameters in serum and skin mucus productions (IgM, ACH50 and T-SOD). Furthermore, dietary BDSA and BDSP could up-regulate the expression of immune related genes (TNF-α, TGF-β and IL-8) and tight junction protein genes (occludin and ZO-1). Dietary BDSB could also elevate the expression of IL-8, TGF-β, ZO-1 and Occludin in the midgut. Although dietary differences of SCFAs didn't alter the α-diversity of the intestinal flora, they altered the core microbiota. Finally, the challenge trial showed that dietary basal diet supplementation with SCFAs could protect zebrafish against Aeromonas hydrophila. These results suggest that dietary SCFAs could improve innate immunity, modulate gut microbiota and increase disease resistance in the host, which indicated the potential of SCFAs as immunostimulants in aquaculture.

    Topics: Aeromonas hydrophila; Animal Feed; Animals; Antioxidants; Diet; Dietary Supplements; Disease Resistance; Fatty Acids, Volatile; Fish Diseases; Gastrointestinal Microbiome; Gram-Negative Bacterial Infections; Interleukin-8; Occludin; Superoxide Dismutase; Transforming Growth Factor beta; Zebrafish

2022
Effects of dietary antimicrobial peptides on intestinal morphology, antioxidant status, immune responses, microbiota and pathogen disease resistance in grass carp Ctenopharyngodon idellus.
    Microbial pathogenesis, 2022, Volume: 165

    This study aims to highlight the effects (8 weeks) of dietary antimicrobial peptides (AMPs, a compound of 6 kDa and 5 kDa from intestine) on intestinal morphological functions and health status in grass carp (Ctenopharyngodon idellus). Fish were supplemented with various gradient concentrations of AMPs, including M0 (0 mg/kg), M1 (100 mg/kg), M2 (200 mg/kg), M3 (400 mg/kg), M4 (800 mg/kg) and M5 (1600 mg/kg). Our results showed that amylase, lipase, chymotrypsin enzymatic levels, and total antioxidant capacity (T-AOC) were significantly increased (p < 0.05), while malondialdehyde (MDA) content was significantly decreased in the intestines of the AMP treated groups compared to the M0. Histological analysis revealed villus height and crypt depth of foregut and midgut in the M4 group were significantly different (p < 0.05) compared to the M0. In the M3 group, the gene expression levels of IL-1β were significantly up-regulated, while levels of IL10 and TGF-β were significantly down-regulated than other treated and control groups. The abundance of Firmicutes was significantly increased (p < 0.05), while the Planctomycetes abundance was decreased at phylum level in M1-M5 groups. Subsequent to the AMP treatment, fish were injected with Aeromonas. hydrophila to assess disease resistant potential. In A. hydrophila injected M3-group, the gene expressions of IL-1β, IL8, and TNF-α were significantly down-regulated while that of TGF-β was significantly up-regulated, and IL10 showed no significant difference compared to the control. Further, AMPs also increased the abundance of the Acidobacteria, Proteobacteria, and Patescibacteria, and decreased the abundance of the Fusobacteria and Firmicutes. Therefore, dietary AMPs (400-800 mg/kg) boosted intestinal health by promoting intestinal morphology, digestive and antioxidant capacities, immunity, and intestinal microbiota in C. idellus.

    Topics: Aeromonas hydrophila; Animal Feed; Animals; Antimicrobial Peptides; Antioxidants; Carps; Diet; Disease Resistance; Fish Diseases; Fish Proteins; Gastrointestinal Microbiome; Gram-Negative Bacterial Infections; Interleukin-10; Intestines; Signal Transduction; Transforming Growth Factor beta

2022
Study about the combination strategy of Bacillus subtilis wt55 with AiiO-AIO6 to improve the resistance of zebrafish to Aeromonas veronii infection.
    Fish & shellfish immunology, 2022, Volume: 128

    Disease problems will seriously restrict the sustainable development of aquaculture, and the environmental-friendly prevention strategies are urgently needed. Probiotics and quorum-quenching enzyme are innovative strategies to control bacterial diseases. Firstly, the bacteriostatic activity of Bacillus subtilis wt55 strain and quenching enzyme AiiO-AIO6 on the growth of Aeromonas veronii were tested in vitro, and the results showed wt55 inhibit the growth of A. veronii, but AiiO-AIO6 did not. Then, the synergistic effects of simple combination of B. subtilis wt55 and AiiO-AIO6 were evaluated next. The results showed this combination could improve the survival rate and significantly reduce the number of invasive A. veronii in gut after challenge compared to the other groups, corresponding to the lower intestinal alkaline phosphatase activity. One of its effect mechanisms is the combination could inhibit the growth of A. veronii in vitro; the other is direct immersion of germ-free zebrafish proved AiiO-AIO6 did not directly regulate the innate immune response of the host, but wt55 did it, and the simple combination group could significantly reduce the expression of nuclear factor kappa-B (NF-κB) and proinflammatory cytokine interleukin-1β (IL-1β), increase the expression of lysozyme gene; and the third is intestinal microbiota also plays a regulatory role: the gut microbiota from combination group could significantly inhibit the expression of IL-1β and NF-κB, and increased the expression of transforming growth factor-β (TGF-β) and lysozyme. Given the effectiveness of this simple combination, a B. subtilis quorum-quenching recombinant expression strain in which AiiO-AIO6 was surface displayed on the spores and secreted by vegetative cells was built. The results showed that the survival rate after challenge was lower than that of the group treated with AiiO-AIO6 or wt55 alone, and the expression of proinflammatory cytokine IL-1β and NF-κB were significantly higher. Our study demonstrated the effectiveness of B. subtilis and AiiO-AIO6 simple combination and established an efficient B. subtilis expression system.

    Topics: Aeromonas veronii; Alkaline Phosphatase; Animals; Bacillus subtilis; Fish Diseases; Gram-Negative Bacterial Infections; Interleukin-1beta; Muramidase; NF-kappa B; Transforming Growth Factor beta; Transforming Growth Factors; Zebrafish

2022
Characterization and immune function of decapentaplegic (Dpp) gene from the oriental river prawn, Macrobrachium nipponense.
    Fish & shellfish immunology, 2020, Volume: 106

    The Decapentaplegic (Dpp) gene, which belongs to the TGF-β superfamily, is involved in multiple developmental processes in eukaryotic species. In this study, we firstly identified and characterized Dpp from Macrobrachium nipponense. Its full-length open reading frame (ORF) cDNA was 1332 bp, encoding 443 amino acids. The putative MnDpp protein contained a signal peptide, a TGF-β propeptide region and a TGF-β domain. Its TGF-β domain was highly conserved from vertebrates to invertebrates, and exhibited highly similarity to Dpp derived from Bombyx mori. qRT-PCR analysis suggested that MnDpp expressed in all tested tissues and responded to both bacterial and virus pathogens, indicating MnDpp was involved in the innate immune response of M. nipponense. Knockdown of MnDppin vivo significantly increased bacteria growth and markedly decreased the expressions of NF-κB signaling genes including dorsal, relish, TAK1, TAB1, Ikkβ and Ikkε as well as antimicrobial peptides (AMPs) including ALF2, ALF3, ALF4, ALF5, Cru1 and Cru2. Moreover, in vitro overexpression of MnDpp protein in HEK293T cells further demonstrated that it exerted antibacterial immune response by activation of NF-κB signaling cascade. In summary, these results indicated that MnDpp played an important role in the innate immunity in M. nipponense by modulating NF-κB signaling pathway, which might provide new insights about Dpp in crustaceans and paved the way for a better understanding of the crustacean innate immune system.

    Topics: Aeromonas hydrophila; Amino Acid Sequence; Animals; Arthropod Proteins; Base Sequence; Cloning, Molecular; DNA Virus Infections; Gram-Negative Bacterial Infections; HEK293 Cells; Humans; NF-kappa B; Palaemonidae; Phylogeny; Transforming Growth Factor beta; White spot syndrome virus 1

2020
Chlorophytum borivilianum Polysaccharide Fraction Provokes the Immune Function and Disease Resistance of Labeo rohita against Aeromonas hydrophila.
    Journal of immunology research, 2015, Volume: 2015

    The present study aimed to investigate the effects of Chlorophytum borivilianum polysaccharide (CBP), as a dietary supplement administered at varying concentrations with feed (basal diet), on various cytokine-related responses in Labeo rohita fingerlings. Immune parameters and immune-related gene expressions were measured at 3rd, 4th, and 5th week after feeding. The results revealed that dietary administration of CBP at 0.2% and 0.4% for 4 weeks significantly upregulated serum lysozyme and phagocytic activity. Complement C3 and respiratory burst activity (RBA) were significantly higher after 4 weeks of CBP feeding. The immune related genes IL-8, IL-1β, TNF-α, and iNOS were downregulated (P < 0.05) in groups with 0.2% and 0.4% CBP supplemented diets at week 4. Expression of anti-inflammatory cytokines (IL-10 and TGF-β) was also downregulated (P < 0.5) after 4 weeks of feeding with 0.2% to 0.8% CBP. However, five weeks of CBP administration had no significant effect on immune gene expression, except TNF-α and IL-8. Fish fed with 0.4% CBP for 4 weeks showed maximum resistance against Aeromonas hydrophila (73.3% survival) compared to control. From these results, we recommend that CBP administration at 0.4% for 4 weeks could effectively improve immune response and disease resistance in L. rohita.

    Topics: Aeromonas hydrophila; Animal Feed; Animals; Complement C3; Cyprinidae; Dietary Supplements; Disease Resistance; Fish Diseases; Gene Expression Regulation; Gram-Negative Bacterial Infections; Immunity, Innate; Interleukin-10; Interleukin-1beta; Interleukin-8; Liliaceae; Muramidase; Nitric Oxide Synthase Type II; Phagocytosis; Polysaccharides; Respiratory Burst; Survival Analysis; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2015
Effect of dietary supplements on cytokine gene expression in rainbow trout, Oncorhynchus mykiss (Walbaum).
    Journal of fish diseases, 2011, Volume: 34, Issue:8

    Topics: Aeromonas hydrophila; Animals; Diet; Dietary Supplements; Fish Diseases; Gene Expression Regulation; Gram-Negative Bacterial Infections; Interleukin-1beta; Interleukin-8; Lupinus; Mangifera; Oncorhynchus mykiss; Transforming Growth Factor beta; Urtica dioica

2011
Cg-TGF-beta, a TGF-beta/activin homologue in the Pacific Oyster Crassostrea gigas, is involved in immunity against Gram-negative microbial infection.
    Developmental and comparative immunology, 2007, Volume: 31, Issue:1

    Transforming growth factor-beta (TGF-beta) members represent a widespread protein superfamily in the animal kingdom, but few members have been characterised in lophotrochozoans, a major clade of invertebrates. Here, we report the identification of Crassostrea gigas-TGF-beta (Cg-TGF-beta), a homologue of vertebrate TGF-beta and activin, from the bivalve mollusc C. gigas. Phylogenetic analysis suggests an early ancestral origin of this subgroup of TGF-beta superfamily member. Investigation of the spatio-temporal expression of Cg-TGF-beta gene by real-time quantitative RT-PCR showed a ubiquitous pattern in all adult tissues. These findings imply that Cg-TGF-beta has multiple functions as described for its vertebrate counterparts. Moreover, Cg-TGF-beta was upregulated in haemocytes during infection by a Gram-negative bacterium, suggesting that it could act as a cytokine involved in immunity in molluscs.

    Topics: Activins; Amino Acid Sequence; Animals; Crassostrea; Cytokines; Gene Expression Regulation; Gram-Negative Bacterial Infections; Molecular Sequence Data; Transforming Growth Factor beta

2007
Endotoxin removal from whole blood by a novel adsorption resin: efficiency and hemocompatibility.
    The International journal of artificial organs, 2004, Volume: 27, Issue:6

    The structural component of Gram- bacteria, endotoxin (ET), induces the release of endogenous mediators of sepsis. Attempts to remove these downstream molecules in vivo, have not improved survival. However, extracorporeal strategies such as continuous renal replacement therapy or therapeutic plasmapheresis have shown benefit. We are presenting an affinity-based extracorporeal technology for the removal of ET from whole blood. The small-scale device contains an adsorbent that removed 75% of ET present in whole blood. This affinity resin displayed good hemocompatibility regarding the coagulation pathway. Minimal platelet, neutrophil and complement activation were observed. There was also no evidence of consumption of coagulation factors or cell loss. In as much as ET participates in both the inflammatory and coagulation abnormalities in sepsis, this method represents an efficient and hemocompatible way to remove ET from whole blood, which, in an extracorporeal setting, may improve the outcome of sepsis.

    Topics: Adsorption; Anti-Infective Agents; Blood Coagulation Factors; Cell Count; Chromatography, Affinity; Complement C3a; Endotoxins; Fibrinogen; Gram-Negative Bacterial Infections; Hemostasis; Humans; Leukocyte Elastase; Ligands; Monocytes; Ofloxacin; Sepharose; Shock, Septic; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2004
SHIP, TGF-beta, and endotoxin tolerance.
    Immunity, 2004, Volume: 21, Issue:2

    Research into the biology of endotoxin (aka lipopolysaccharide; LPS) began well over 100 years ago and has had many unexpected turns. The phenomenon of endotoxin tolerance was among these and has engendered immense curiosity over the years. Sly and colleagues (this issue of Immunity) have taken an important step toward understanding the phenomenon of endotoxin tolerance and have enhanced our comprehension of LPS signaling as a whole by demonstrating that the cytosolic phosphatase SHIP is required to permit the development of an LPS-refractory state in macrophages and mice.

    Topics: Animals; Endotoxins; Feedback, Physiological; Gram-Negative Bacterial Infections; Immune Tolerance; Lipopolysaccharides; Mice; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Phosphoric Monoester Hydrolases; Transforming Growth Factor beta

2004